Found: 16
Select item for more details and to access through your institution.
Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma.
- Published in:
- Cancer & Metabolism, 2024, v. 12, n. 1, p. 1, doi. 10.1186/s40170-024-00341-7
- By:
- Publication type:
- Article
Androgen and oestrogen receptor co-expression determines the efficacy of hormone receptor-mediated radiosensitisation in breast cancer.
- Published in:
- British Journal of Cancer, 2022, v. 127, n. 5, p. 927, doi. 10.1038/s41416-022-01849-9
- By:
- Publication type:
- Article
Androgen and oestrogen receptor co-expression determines the efficacy of hormone receptor-mediated radiosensitisation in breast cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Publisher Correction: Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00397-y
- By:
- Publication type:
- Article
Epigenetically defined therapeutic targeting in H3.3G34R/V high-grade gliomas.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 615, p. 1, doi. 10.1126/scitranslmed.abf7860
- By:
- Publication type:
- Article
Purine metabolism regulates DNA repair and therapy resistance in glioblastoma.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-17512-x
- By:
- Publication type:
- Article
Seviteronel, a Novel CYP17 Lyase Inhibitor and Androgen Receptor Antagonist, Radiosensitizes AR-Positive Triple Negative Breast Cancer Cells.
- Published in:
- Frontiers in Endocrinology, 2020, v. 11, p. 1, doi. 10.3389/fendo.2020.00035
- By:
- Publication type:
- Article
TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Tissue of origin dictates GOT1 dependence and confers synthetic lethality to radiotherapy.
- Published in:
- Cancer & Metabolism, 2020, v. 8, n. 1, p. 1, doi. 10.1186/s40170-019-0202-2
- By:
- Publication type:
- Article
EXTH-15. TARGETING ANDROGEN SIGNALING IN GLIOBLASTOMA (GBM) USING SEVITERONEL (SEVI), A CYP17 LYASE AND ANDROGEN RECEPTOR (AR) INHIBITOR, ALONE AND IN COMBINATION WITH RADIATION (RT).
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi88, doi. 10.1093/neuonc/noy148.364
- By:
- Publication type:
- Article
Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer.
- Published in:
- NPJ Breast Cancer, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41523-017-0038-2
- By:
- Publication type:
- Article
The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression.
- Published in:
- Nature Communications, 2016, v. 7, n. 9, p. 12791, doi. 10.1038/ncomms12791
- By:
- Publication type:
- Article
Development and Validation of a Novel Platform-Independent Metastasis Signature in Human Breast Cancer.
- Published in:
- PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0126631
- By:
- Publication type:
- Article
Targeted radiosensitization with PARP1 inhibition: optimization of therapy and identification of biomarkers of response in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 147, n. 1, p. 81, doi. 10.1007/s10549-014-3085-5
- By:
- Publication type:
- Article
Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer.
- Published in:
- Nature, 2014, v. 510, n. 7504, p. 278, doi. 10.1038/nature13229
- By:
- Publication type:
- Article